Sort
51,570 grants matching “autoimmune disease”
Behavioral Smoking Cessation Treatment for People Living with HIV/AIDS
$445,004David M Ledgerwood · Wayne State University · R01 · FY2015 · DA
Engineering dendritic cells to target islet antigen to pro-tolerogenic subsets for prevention and treatment of Type 1 Diabetes
$445,000Judith Agudo Cantero · Dana-Farber Cancer Inst · R01 · FY2023 · DK
Engineering dendritic cells to target islet antigen to pro-tolerogenic subsets for prevention and treatment of Type 1 Diabetes
$445,000Judith Agudo Cantero · Dana-Farber Cancer Inst · R01 · FY2022 · DK
Macrophages in human autoimmune tissue pathology
$445,000Laura T. Donlin · Hospital For Special Surgery · R01 · FY2021 · AI
Macrophages in human autoimmune tissue pathology
$445,000Laura T. Donlin · Hospital For Special Surgery · R01 · FY2023 · AI
Engineering dendritic cells to target islet antigen to pro-tolerogenic subsets for prevention and treatment of Type 1 Diabetes
$445,000Judith Agudo Cantero · Dana-Farber Cancer Inst · R01 · FY2025 · DK
Macrophages in human autoimmune tissue pathology
$445,000Laura T. Donlin · Hospital For Special Surgery · R01 · FY2020 · AI
Macrophages in human autoimmune tissue pathology
$445,000Laura T. Donlin · Hospital For Special Surgery · R01 · FY2024 · AI
Engineering dendritic cells to target islet antigen to pro-tolerogenic subsets for prevention and treatment of Type 1 Diabetes
$445,000Judith Agudo Cantero · Dana-Farber Cancer Inst · R01 · FY2024 · DK
Macrophages in human autoimmune tissue pathology
$445,000Laura T. Donlin · Hospital For Special Surgery · R01 · FY2022 · AI
Innate Gut Epithelial Mechanisms of Immunity
$445,000Mark Bix · St. Jude Children'S Research Hospital · R56 · FY2014 · AI
Toll Pathway & Control of Adaptive Immune Responses
$444,993Ruslan Medzhitov · Yale University · R01 · FY2011 · AI
Complement driven innate and adaptive autoreactivity in lung transplantation
$444,968Carl Atkinson · University Of Florida · R01 · FY2021 · HL
Tissue and organ specific human B cell immunity
$444,936Frances E. Lund · University Of Alabama At Birmingham · U19 · FY2020 · AI
Tissue and organ specific human B cell immunity
$444,936Frances E. Lund · University Of Alabama At Birmingham · U19 · FY2021 · AI
S1P Receptor subtypes: Regulating lymphocyte trafficking
$444,933Hugh Rosen · Scripps Research Institute, The · R01 · FY2007 · AI
A cytokine that promotes dendritic cell survival
$444,923Yongwon Choi · University Of Pennsylvania · R01 · FY2007 · AI
Costimulatory and Coinhibitory Receptor Control of Alloreactive T Cell Responses
$444,920Mandy L. Ford · Emory University · R01 · FY2015 · AI
Unveiling the hidden regulators: deciphering endogenous retroelement control of allergic Type 2 immune response
$444,920Pedro Gazzinelli Guimaraes · George Washington University · DP2 · FY2025 · AI
Pharmacogenetics of Post-ACS Therapy
$444,920Howard L McLeod · Washington University · P50 · FY2009 · HL
Autoimmunity and Immunopathology Training Program
$444,891Mark J Shlomchik · University Of Pittsburgh At Pittsburgh · T32 · FY2016 · AI
Transcriptional Regulation of Immune Cell Development, Activation and Functions
$444,859Jinfang Zhu · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
The Blimp-1 SLE risk variant regulates inflammatory function in dendritic cells
$444,840Sun Jung Kim · Feinstein Institute For Medical Research · R01 · FY2015 · AR
The Blimp-1 SLE risk variant regulates inflammatory function in dendritic cells
$444,840Sun Jung Kim · Feinstein Institute For Medical Research · R01 · FY2017 · AR
The Blimp-1 SLE risk variant regulates inflammatory function in dendritic cells
$444,840Sun Jung Kim · Feinstein Institute For Medical Research · R01 · FY2016 · AR